Vaxcyte Inc (PCVX) Company Profile & Statistics

Vaxcyte Inc
PCVX
(Nasdaq - US)
N/A
58.96
-1.34 (-2.22%)
in:usd•As of: Apr 25, 2024 10:01 UTC -4
Open
60.06
High
60.06
Low
58.72

About Vaxcyte Inc

CEO

Grant E. Pickering

Headquarters

825 industrial road, suite 300

san carlos, ca 94070, united states

Auditor

Deloitte & Touche LLP

Employees

254

Share Holders

Website

www.vaxcyte.com

Industry

biotechnology

Sector

health technology

Company Overview

Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.

Vaxcyte Inc Statistics

Valuation Measures

Market Capitalization ²	6.41B
Enterprise Value	6.02B
Enterprise Value/EBITDA (ttm)	-12.21
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.67
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-32.04%
Return on Invested Capital (ttm)	-32.35%
Return on Assets (ttm)	-29.72%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-492.65M
Net Income Avi to Common (ttm)	-402.27M
Diluted EPS (ttm)	-4.13

Share Statistics

Beta (5Y Monthly)	0.89
52-Week Change	35.82%
S&P500 52-Week Change	22.97%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	108.41M
Dividend Yield	0.00%
Float ⁴	104.84M
% Held by Insiders	3.60%
% Held by Institutions	96.78%

Balance Sheet

Total Cash (mrq)	1.08B
Total Cash Per Share (mrq)	9.96
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	7.54%
Quick Ratio (mrq)	7.54%
Book Value Per Share (mrq)	13.01

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.05
Free Cash Flow (ytd)	-312.85M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Vaxcyte Inc

Trade With A Regulated Broker